Access the full text.
Sign up today, get DeepDyve free for 14 days.
Poblotzki Poblotzki, Gigler Gigler, Lang Lang, Wolf Wolf, Modrow Modrow (1995a)
Antibodies to the non‐structural protein NS‐1 of parvovirus B19 in infected individualsJournal of General Virology, 76
G. Enders, J. Dötsch, J. Bauer, W. Nützenadel, H. Hengel, D. Haffner, G. Schalasta, K. Searle, K. Brown (1998)
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 26 2
A. Poblotzki, A. Gigler, B. Lang, H. Wolf, S. Modrow (1995)
Antibodies to parvovirus B19 NS-1 protein in infected individuals.The Journal of general virology, 76 ( Pt 3)
K. Brown, S. Green, J. Mayolo, N. Young, J. Bellanti, S. Smith, Tj Smith (1994)
Congenital anaemia after transplacental B19 parvovirus infectionThe Lancet, 343
Enders Enders, Dotsch Dotsch, Bauer Bauer, Nützenadel Nützenadel, Hengel Hengel, Haffner Haffner, Schalasta Schalasta, Searle Searle, Brown Brown (1998)
Two case reports: Life‐threatening parvovirus B19 associated myocarditis and cardiac transplantation as a possible therapyClinical Infectious Diseases, 26
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
M. Anderson, S. Jones, S. Fisher-Hoch, E. Lewis, S. Hall, C. Bartlett, B. Cohen, P. Mortimer, M. Pereira (1983)
HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 321
Schwarz Schwarz, Nerlich Nerlich, Roggendorf Roggendorf, Hottentrager Hottentrager, Jager Jager, Schramm Schramm, Gloning Gloning, Roggendorf Roggendorf (1990)
Parvovirus B19 infection in pregnancyInternational Journal of Experimental and Clinical Chemotherapy, 3
Searle Searle, Guilliard Guilliard, Wallat Wallat, Schalasta Schalasta, Enders Enders (1998)
Acute parvovirus B19 infection in pregnant women—An analysis of serial samples by serological and semi‐quantitative PCR techniquesInfection, 26
Searle Searle, Guilliard Guilliard, Enders Enders (1997)
Parvovirus B19 diagnosis in pregnant women—Quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serumInfection, 25
J. Pattison, S. Jones, J. Hodgson, L. Davis, J. White, C. Stroud, L. Murtaza (1981)
PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIAThe Lancet, 317
C. Fairley, J. Smoleniec, Owen Caul, E. Miller (1995)
Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infectionThe Lancet, 346
British Medical Journal, 300
A. Woolf, G. Campion, Alice Chishick, S. Wise, B. Cohen, P. Klouda, Owen Caul, P. Dieppe (1989)
Clinical manifestations of human parvovirus B19 in adults.Archives of internal medicine, 149 5
D. Reid, T. Brown, T. Reid, J. Rennie, C. Eastmond (1985)
HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 325
T. Finkel, D. Leung, R. Harbeck, E. Gelfand, T. Török, S. Zaki, L. Anderson, P. Ferguson, F. Saulsbury, E. Durigon, J. Hollister (1994)
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?The Lancet, 343
Y. Yoto, T. Kudoh, K. Haseyama, N. Suzuki, Shigeru Chiba (1996)
Human parvovirus B19 infection associated with acute hepatitisThe Lancet, 347
A. Poblotzki, A. Hemauer, A. Gigler, E. Puchhammer-Stöckl, F. Heinz, J. Pont, K. Laczika, H. Wolf, S. Modrow (1995)
Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.The Journal of infectious diseases, 172 5
At present little is known about the mechanisms influencing the course and severity of parvovirus B19 infection. Antibodies to the parvovirus nonstructural protein NS1 were reported in patients with parvovirus‐associated arthritis and those with persisting infection but not in those without complications, suggesting a potential involvement of NS1 or anti‐NS1 antibodies in pathogenesis. The immune response to NS1 was examined retrospectively in 33 pregnant women with acute parvovirus B19 infection, 14 of whom experienced symptomatic infection and 19 in whom the infection was subclinical. Antibodies to NS1 were found in 15 (45%) of the women, seven with symptomatic and eight with subclinical infection. No association was found between the development of anti‐NS1 antibodies and the occurrence of fetal complications. Of the seven cases in which fetal complications were observed, anti‐NS1 antibodies were detected in only three. The finding that an immune response to NS1 can also be demonstrated in patients with asymptomatic infection suggests that anti‐NS1 antibodies do not appear to represent a marker for an altered or severe course of infection in pregnant women or to contribute significantly to pathogenesis. Since anti‐NS1 antibodies first become detectable at least six weeks postinfection, their presence can be used to exclude acute infection in patients with unclear serology or be used to aid differential diagnosis of rashlike illnesses. J. Med. Virol. 56:192–198, 1998. © 1998 Wiley‐Liss, Inc.
Journal of Medical Virology – Wiley
Published: Nov 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.